Occidental Asset Management, LLC Novartis Ag Transaction History

Occidental Asset Management, LLC

$530 Million
Q1 2024

A detailed history of Occidental Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Occidental Asset Management, LLC holds 2,500 shares of NVS stock, worth $266,100. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,500

Previous 2,490 0.4%

Holding current value

$266,100

Previous $251,000 3.98%

% of portfolio

0.05%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$95.27 - $108.47 $952 - $1,084	10 Added 0.4%	2,500 $241,000
Q4 2023 Jan 18, 2024	SELL	$92.27 - $101.54 $104,541 - $115,044	-1,133 Reduced 31.27%	2,490 $251,000
Q3 2023 Oct 18, 2023	SELL	$94.73 - $105.13 $7,578 - $8,410	-80 Reduced 2.16%	3,623 $369,000
Q2 2023 Jul 11, 2023	SELL	$92.52 - $104.91 $20,817 - $23,604	-225 Reduced 5.73%	3,703 $373,000
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $2,160 - $2,505	-27 Reduced 0.68%	3,928 $361,000

Q4 2022 Jan 23, 2023	BUY	$75.55 - $92.52 $64,217 - $78,642	850 Added 27.38%	3,955 $0
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $31,885 - $37,125	-396 Reduced 11.31%	3,105 $262,000
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $560 - $634	7 Added 0.2%	3,501 $307,000
Q4 2021 Feb 01, 2022	BUY	$79.7 - $88.13 $717 - $793	9 Added 0.26%	3,494 $306,000
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $3,256 - $3,840	-39 Reduced 1.11%	3,485 $298,000
Q4 2020 Jan 28, 2021	SELL	$78.07 - $94.43 $3,981 - $4,815	-51 Reduced 1.43%	3,524 $333,000
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $6,406 - $7,098	-78 Reduced 2.14%	3,575 $311,000
Q2 2020 Jul 17, 2020	SELL	$80.93 - $91.1 $3,479 - $3,917	-43 Reduced 1.16%	3,653 $319,000
Q1 2020 Apr 23, 2020	BUY	$70.67 - $99.01 $8,339 - $11,683	118 Added 3.3%	3,696 $305,000
Q4 2018 Mar 19, 2019	BUY	$73.66 - $82.02 $3,609 - $4,018	49 Added 1.39%	3,578 $307,000
Q3 2018 Mar 19, 2019	SELL	$66.94 - $77.43 $13,388 - $15,486	-200 Reduced 5.36%	3,529 $304,000
Q2 2018 Mar 19, 2019	SELL	$64.91 - $73.36 $63,546 - $71,819	-979 Reduced 20.79%	3,729 $282,000
Q4 2017 Mar 19, 2019	BUY	$72.33 - $77.64 $1,880 - $2,018	26 Added 0.56%	4,708 $395,000
Q3 2017 Mar 19, 2019	SELL	$74.14 - $77.27 $7,414 - $7,727	-100 Reduced 2.09%	4,682 $402,000
Q2 2017 Mar 19, 2019	SELL	N/A	-100 Reduced 2.05%	4,782 $399,000
Q1 2017 Mar 19, 2019	SELL	N/A	-225 Reduced 4.41%	4,882 $363,000
Q4 2016 May 15, 2019	SELL	N/A	-107 Reduced 2.05%	5,107 $372,000
Q3 2016 May 15, 2019	BUY	N/A	21 Added 0.4%	5,214 $412,000
Q2 2016 May 15, 2019	BUY	N/A	1,095 Added 26.72%	5,193 $428,000
Q4 2014 Jun 17, 2019	SELL	N/A	-880 Reduced 17.68%	4,098 $380,000
Q1 2014 Jun 17, 2019	BUY	N/A	4,978	4,978 $423,000

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.

Account

Occidental Asset Management, LLC Novartis Ag Transaction History